Have a personal or library account? Click to login
CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review Cover

CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review

Open Access
|Mar 2023

Figures & Tables

FIGURE 1

(A) Morphology of diffuse large B-cell lymphoma (DLBCL), CD56+; H&E, 20x; (B) Strong expression of CD56 in DLBCL not otherwise specified (NOS) (tissue microarray), 4x; (C) weak to moderate CD56 expression in DLBCL NOS (tissue microarray), 4x.
(A) Morphology of diffuse large B-cell lymphoma (DLBCL), CD56+; H&E, 20x; (B) Strong expression of CD56 in DLBCL not otherwise specified (NOS) (tissue microarray), 4x; (C) weak to moderate CD56 expression in DLBCL NOS (tissue microarray), 4x.

Genetic profile of CD56 positive diffuse large B-cell lymphoma (DLBCL) samples

Case number in Table 2COO IHCCOO AFPLfusionvariantsVAF (%)variant classiificationSchmitz et al., 201832 classification
genenucleotide changeamino acid change
1GCBGCBNDRANBP1NM_002882.3:c.23A>GNP_002873.1:p.(His8Arg)13,7Uncertain significanceunclassified
2GCBGCBNDNDNDNDNDNDunclassified
3GCBGCBNDCD79BNM_000626.2:c.587A>TNP_000617.1:p.(Tyr196Phe)49,0PathogenicEZB
CD79BNM_000626.2:c.568A>GNP_000617.1:p.(Met190Val)50,1Uncertain significance
EZH2NM_001203247.1:c.1922A>GNP_001190176.1:p.(Tyr641Cys)53,7Pathogenic
MYD88NM_001172567.1:c.656C>GNP_001166038.1:p.(Ser219Cys)37,7Uncertain significance
SH3BP5NM_004844.4:c.460G>ANP_004835.2:p.(Ala154Thr)19,3Uncertain significance
4ABCABCIGH-BCL6CD79BNM_000626.2:c.587A>CNP_000617.1:p.(Tyr196Ser)25,9PathogenicBN2
SH3BP5NM_004844.4:c.460G>ANP_004835.2:p.(Ala154Thr)12,6Uncertain significance

Clinicopathological characteristics of patients with CD56 positive diffuse large B-cell lymphoma (DLBCL), review of the literature with our series

PublicationCounNo of patCase NoSex AgeGC type**Non-GC typeLNExtranodal disease and siteClinical stageIPILDHSurgCT and No. of cyclesRTResponseFU
Kern 199323USA11NANANANANANANANANANANANANA
Muroi 199817Jap21M,49Yes YesLiver, Spleen, Pericard. Ef. LiverNANANANoCHOP, NAxNoPR?NA
2F,62 YesYesNANANANoCHOP, NAxNoPR?NA
Sekita 199918Jap11M,16Yes Yes INANANoCHOP, 6xNoCR10 m
Hammer 199815USA41M,51NANAYesStomachNANANA NANANANA
2M,69NANANo NANANA NANANANA
3M,76NANAYes NANANA NANANANA
4M,54NANAYes NANANA NANANANA
Otsuka 200414Jap21NAYes NANANANANANANANANANA
2NAYes NANANANANANANANANANA
Weisberger *200611 1M,41YesYesNoIleocecal valveNANANANANANANANA
USA102M,52Yes YesSpineAbdomen BrainNANANANANANANANA
3M,54Yes Yes NANANANANANANANA
4M,83Yes No NANANANANANANANA
5M,49Yes Yes NANANANANANANANA
6F,57Yes No NANANANANANANANA
7F,69Yes Yes NANANANANANANANA
8M,77Yes Yes NANANANANANANANA
9M,84Yes Yes NANANANANANANANA
10M,77 No NANANANANANANANA
Isobe 200713Jap31M,80Yes YesAscitesNANANANoTHP-COP, 3xNoNRDOD
2F,87Yes NoIleumNANANAYesNoNoCR22 m
3M,73Yes YesIleumNANANAYesR-CHOP, 6xNoCR22 m
Chen 201016Ch11NANANANANANA NANANANANANA
Gomyo 20109Jap71M,29 YesYesSpleenIIIBHINoR-CHOP, aPBSCTNoCRA, 24 m
2F,60 YesYesWRIIALNNoR-CHOP 3xYesCRA, 50 m
3F,22Yes NoWRIALNNoCHOP 3xYesCRA, 57 m
4M,64 YesYesPl. Ef, Adr. gl, Submand. glIIIAHNoCHOP 5xNoCRD, 4 m
5M,63Yes NoNasal cavityIALNNoRCHOP 3xYesCR(pneumonia)
6M,50Yes NoIntra-extradural massIALNNoRes+CHOP 4xYeRCRA, 43 m
7F,45Yes NoSubcutisIVAHINoR-CHOP 8xsNo A, 70 mA, 5 m
Stacchini 201212It51M,72Yes YesSpleen, Stomach, Pancr.NANANANANANANANA
2M,15Yes YesStomach, LiverNANANANANANANANA
3M,71Yes NoNasopharynxNANANANANANANANA
4M,60 NANANANANANANANA
5M,21YesYesNo NANANANANANANAAWD 12m
Gu 201310SK11F,5 Yes WRI NYesCOPAD, 6xNoCRNA
Liu 20208Ch11M,14Yes, DH YesNasopharynxIVNANoCTX+CPNoCRNA
R-Hyper-CVAD AB
R-DA-EPOCH, 6x
IT DM+CTB,4x
Gasljevic 2022Slo71F,56Yes YesSkeletal muscleIA0NYesR-CHOP, 3xNoCRA, 63 m
2F,51Yes YesSmall bowelIA0NNoR-CHOP, 3xNoCRA, 73 m
3M,57Yes IIA0NoR-CHOP, 6xNoCRA, 55 m
4M,56 Yes, DE Spleen, Liver, Adrenal glandIVB0NoR-EPOCH,6x +IT,2xNoCRA, 40 m
5F,53Yes YesIIA3NYesCHOP, 3xYesCRA, 62 m
6F,30 YesYes IVB3NoR-CHOP,8xYesCRA, 182 m
7F,79NANAYes IVB5NoNoNoNADOD
DOI: https://doi.org/10.2478/raon-2023-0016 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 249 - 256
Submitted on: Jan 9, 2023
Accepted on: Feb 19, 2023
Published on: Mar 21, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2023 Gorana Gasljevic, Lucka Boltezar, Srdjan Novakovic, Vita Setrajcic-Dragos, Barbara Jezersek-Novakovic, Veronika Kloboves-Prevodnik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.